Skip to content
Not many people know what amyloidosis is, and for Mike Lane, Founder of the Amyloidosis Army, that’s a problem he wants to change. “That’s […]
Amyloidosis: Under-diagnosed disorder with serious consequences Read More »
It has been three years since the Inflation Reduction Act (IRA) was signed into law. “We have definitively seen negative impacts on patient access,
BIO Coffee Chat looks at patient access after three years of the IRA Read More »
A Rat sarcoma (RAS) mutation is an oncogene, a gene that causes cancer when mutated. The RAS is the most commonly mutated oncogene in
Startup Stadium: Tezcat Biosciences targets common cancer mutation Read More »
Over 8 million people in the U.S., and 125 million worldwide, live with psoriasis—about 2–3% of the population. Far from being a simple cosmetic
Psoriasis awareness: The condition is more than skin deep Read More »
“Initial weight loss is just the first chapter,” said Mia de Graaf, Deputy Executive Health Editor at Business Insider, “but the real challenge and
BIO 2025: How weight loss drugs are disrupting chronic disease Read More »
When experts discussed clinical uses of psychedelics two years ago at the 2023 Biotechnology Innovation Organization (BIO) International Convention, there was some interest in
BIO 2025: Psychedelics go mainstream – what’s next? Read More »
For most of her life, the only things coming out of left field for Kristin Smedley were fly balls, but with the birth of
Mother inspired to support solutions for her boys’ blindness Read More »
“Small companies are the lifeblood of the industry and a lot of what they do, and what they’re experiencing, greatly affects the industry as
Emerging biotechs get bearish to weather market trends, finds BIO report Read More »
Prostate cancer is the most common solid cancer among men, with 1 in 8 men being diagnosed in their lifetime and 1 in 44
Three questions men can ask about prostate cancer Read More »
As the United States has long been a life sciences leader, the health of the life sciences sector is a pretty good indicator of
Life sciences job report shows growth slowing, but firms still invest in talent Read More »
